Drug-induced hypersensitivity syndrome after initiation of darunavir and raltegravir

Rev Soc Bras Med Trop. 2017 Jul-Aug;50(4):575-576. doi: 10.1590/0037-8682-0373-2016.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Darunavir / adverse effects*
  • Drug Hypersensitivity Syndrome / etiology*
  • Female
  • HIV Infections / drug therapy
  • Humans
  • Raltegravir Potassium / adverse effects*
  • Raltegravir Potassium / therapeutic use

Substances

  • Anti-HIV Agents
  • Raltegravir Potassium
  • Darunavir